NovelMed Advances NM5072 for Multiple Ocular Disorders

Key Highlights

  • Multi-indication precedent: Biogen’s approximately $5.6 billion acquisition of Apellis added EMPAVELI for PNH and SYFOVRE for GA, both of which contain pegcetacoplan.
  • Primate proof of concept: A single intravitreal dose of NM5072 reduced CNV, hemorrhage, and retinal fibrosis in a rhesus monkey model.
  • Phase I clinical experience: NM5072 completed a Phase I study in 48 healthy volunteers and received FDA Orphan Drug Designation for PNH.
  • Potential extended durability: Rabbit PK/PD data estimated an ocular half-life of seven days. Translational modeling projects approximately 21 days in humans, with therapeutic levels maintained for up to 140 days.

CLEVELAND, Aug. 11, 2026 (GLOBE NEWSWIRE) -- NovelMed Therapeutics, Inc., a clinical-stage biotechnology company, announced that it is advancing NM5072 as an ocular development candidate for multiple complement-associated retinal diseases. The program is supported by efficacy findings in rhesus monkey and rabbit models, as well as Phase I clinical safety data.

Municipal Water System Attacks Spotlight Insecure Industrial Systems

Water treatment plant in Oakland, California

Water treatment systems and other industrial automation sites are often unsecured against a range of cybersecurity threats.

Getty Images

Attackers hit municipal water systems in at least 12 states beginning July 27, 2026, interrupting critical monitoring and control functions at some utilities by changing IP addresses and passwords on internet-facing programmable logic controllers. The FBI reported that at least one victim’s PLC programming was modified. The news about this had little technical detail, so I decided to dig deeper.

PRCT FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages PROCEPT BioRobotics Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities...

New York, New York--(Newsfile Corp. - August 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"), of the important September 22, 2026 lead plaintiff deadline.

Riot Platforms strikes deal with Anthropic as bitcoin miners shift focus to AI infrastructure

Cheng Xin | Getty Images News | Getty Images

Bitcoin miner Riot Platform has struck a $9 billion, 20-year compute deal with Anthropic, CNBC's David Faber has confirmed.

The agreement would lease 191 megawatts at Riot's Rockdale, Texas computer campus, giving Anthropic access to scarce, grid-connected power as demand surges for computing power that can be used to provide artificial intelligence – and transitioning Riot from bitcoin miner to AI infrastructure landlord. Shares initially soared more than 20% in reaction before giving up almost the entire gain.

Bitter Lessons From The EMR For The AI Experiment

Doctor uses desktop PC in hospital ward to update records

The mature adult female doctor uses the desktop PC in the hospital ward to update electronic patient records.

getty

Few interventions have altered the daily practice of medicine as thoroughly as the digitization of the medical record. The landscape of care is now mediated by “screens”. For most clinicians, the dominant interaction of the workday is no longer with a patient, but with a keyboard — and that shift arrived with enormous cost, substantial unintended consequences, and remarkably little prospective evaluation.

Quordle Hints Today: Wednesday, August 12 Clues And Answers

Here's some help with today's Quordle, including hints and the answers.

Here's some help with today's Quordle, including hints and the answers.

SOPA Images/LightRocket via Getty Images

Before today’s Quordle hints and answers, here’s what you missed on Tuesday:

Trump wants to split the MMR vaccine. Experts say that's unlikely — and comes with consequences

Trumps signs order to cut child vaccine recommendations from 18 to 11

watch now

President Donald Trump's latest executive order calls for splitting the measles, mumps and rubella, or MMR, vaccine into three separate shots – but doctors and other experts say that effort has no scientific basis and is unlikely to get off the ground. 

Baby products company Frida is expanding into kids’ personal care

Frida For Kids

Courtesy: Frida for Kids

Baby products company Frida is expanding into a line of personal care products for kids ages 6 to 11 that will be sold in Walmart and on Amazon, the company told CNBC exclusively.

AI Data Centers Are Driving Up Electric Bills. Who Pays?

STOP AI Protest

Red STOP AI protest flyer with meeting details taped to a light pole on a sunny city street, San Francisco, California, May 20, 2025. (Photo by Smith Collection/Gado/Getty Images)

Council Post: Half Your Workforce Already Bypassed Your AI Policy

Keegan Crage | Owner, TechBrain AU — ISO 27001 certified, cyber security & AI governance partner.

getty

​Nine in 10 organizations claim to have an AI policy in place, yet 70% of IT leaders have already caught their staff using unapproved AI at work. Telemetry from one of the largest annual breach studies has found employee use of AI on business devices has tripled in the last 12 months.